key: cord-0732210-nm12lk2h authors: Kobayashi, Ken-ichiro; Kaki, Takahiro; Mizuno, Shinsuke; Kubo, Kenji; Komiya, Nobuhiro; Otsu, Satoko title: Clinical characteristics of patients with COVID-19 in Japan: a single-center case series date: 2020-05-08 journal: J Infect Dis DOI: 10.1093/infdis/jiaa244 sha: 8c40a17230ded18a417fbdda36cd495068c04fb8 doc_id: 732210 cord_uid: nm12lk2h We report a case series of 6 patients with confirmed COVID-19 in Wakayama prefecture, Japan. All 6 of the patients tested positive in pharyngeal swab PCR tests, and 2 of the 6 were still positive at 3 weeks after onset. All of the patients exhibited bilateral ground glass opacities (GGO) on computed tomography (CT). This paper also reports narrative information on the spectrum of symptoms collected directly from the patients. It would be difficult to triage patients with COVID-19 based on the typical symptoms of fever and/or cough, although PCR and CT are definitive in diagnosis. A c c e p t e d M a n u s c r i p t 4 Background The novel coronavirus disease (COVID-19) caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2) has been spreading since the outbreak of the disease in China in December of 2019. The number of COVID-19 cases in Japan has been climbing since mid-February. As of April 26, 2020, 12,388 cases confirmed cases in Japan have been recorded(1). Fifty-eight cases have been reported in Wakayama prefecture, Japan. A new infectious disease law enacted in Japan in February 2020 to manage COVID-19 provides that patients with confirmed COVID-19 must be hospitalized at specialized hospitals for infectious diseases, and that two consecutive negative PCR results are required for discharge after a patient's symptoms improve. While the clinical characteristics of COVID-19 have been reported from China (2), they have not been well understood outside of China. In this report we describe a series of patients with confirmed COVID-19 who were treated in our hospital in Wakayama prefecture in February 2020. This single-centered, retrospective observational study was conducted at the Japanese Red Cross Wakayama Medical Center (Wakayama, Japan: 873 beds) with a specialized ward for infectious diseases. This study was approved by the Ethical Committee of the Japanese Red Cross Wakayama Medical Center on February 26, 2020. We retrospectively analyzed patients with confirmed COVID-19 who were hospitalized from February 13 to 25, 2020. Each case presentation includes narrative information describing how the patients felt or interpreted their symptoms and excludes personally identifiable information. SARS-A c c e p t e d M a n u s c r i p t 5 CoV-2 was detected by performing a polymerase chain reaction (PCR) tests on specimens of either sputum or pharyngeal swabs, or of both, according to laboratory guidance from the Ministry of Health, Labor and Welfare (3) . The patients were diagnosed with COVID-19 diagnosed if two conditions were met: 1) any clinical symptoms and 2) a positive PCR result. The day when symptoms appeared is counted as the first day of illness (Day 1). A male in his 50s with known hypertension developed fatigue and fever, followed by abdominal pain on Day 6. Upon noting blood in his stool, he suspected that his abdominal pain was caused by "ischemic colitis." A computed tomography (CT) image taken on Day 7 to investigate his abdominal pain showed bilateral ground glass opacity (GGO) of the lungs. He was treated with antibiotics and corticosteroid for pneumonia. Rapid Influenza Diagnostic Tests (RIDTs) were negative on Day 6 and Day 9. His fever and abdominal pain persisted for 12 days and 9 days, respectively. A PCR test for SARS-CoV-2 performed on Day 13 was positive. His next two PCR tests, on Days 15 and 16, respectively, were negative. A male in his 60s with colon cancer developed a cough (Day 1) and was admitted to a hospital for colorectal cancer surgery on Day 8. A CT scan was performed on Day 9, because the patient exhibited a low-grade fever, chills, and a worsening cough. The CT image showed bilateral GGO of the lungs and his surgery was postponed. His cough remained mild, which led him to believe he was suffering from a "common cold," until he was diagnosed with pneumonia. A PCR test of a pharyngeal A c c e p t e d M a n u s c r i p t 6 swab was positive, and the patient was referred to our hospital, on Day 14. The patient has been afebrile since Day 16. The consecutive PCR test results finally turned negative on Day 25. A male in his 50s presented to a clinic on the second day of fever. Antibiotics and antitussive were prescribed. Shortly later he visited a hospital with persistent fever and headache. He suffered a high grade fever and headache. The headache, he reported, felt like "a heated iron plate in his head." He was suspected of COVID-19 based on CT imaging and referred to our hospital on Day 6. A PCR test on We have described six confirmed cases with COVID-19 in Wakayama prefecture, Japan. Cough was less frequent (33% vs 82%) and gastrointestinal symptoms were more frequent (33% vs 3%) in our study than in the previous study (2) . Nearly 20% of reported patients with COVID-19 in China have developed severe pneumonia (4). Empiric therapy with anti-microbial agents (antibiotics and antiinfluenza agents) are recommended in the therapeutic strategy applied in Wuhan, China (5). In contrast, none of the patients in our study have been administered anti-microbial agents, and all of them have had mild symptoms and no signs of severe pneumonia. According to Zou L et al., the higher viral loads detected in the nasal passages or throats of patients soon after symptom onset suggested that the SARS-CoV-2 infection followed a pattern resembling that of influenza. In most of the patients infected with SARS-CoV-2, the viral load was markedly reduced within two weeks after symptom onset (6) . Nevertheless, SARS-CoV-2 was detected in our A c c e p t e d M a n u s c r i p t 9 patients three weeks after onset, after their symptoms had already settled down (Figure 1 ). This finding suggests that infection prevention and control measures are still required after patients recover. The follow-up CT image of patient 3 suggested that consolidated opacities can be found after the symptoms improve. This finding is consistent with a previous study showing that consolidation in CT images was more frequently detected in the late stage after COVID-19 onset, compared to the early stage (7) . The consolidated opacities found after symptom abatement also suggest that it can be difficult to detect pneumonia by chest X-ray in COVID-19 patients at the early stage of the clinical course. The strength of our study is the narrative information directly taken from the patients. As the terms patients use to describe their symptoms differ from those used by health personnel (8) , their complaints should be categorized and/or classified using medical terminology to summarize their clinical characteristics in a descriptive study with a large number of cases. A careful recording of the patients' own descriptions of their histories could reveal how common symptoms of COVID-19, such as fever or cough, differ from the symptoms of other acute respiratory infections. A third of our patients experienced gastrointestinal symptoms, and one of the patients with gastrointestinal symptoms was free of respiratory symptoms. We know, therefore, that grounds for suspecting pneumonia may be absent in some COVID-19 patients. A previous study reported that healthcare workers were presumed to have been infected by a single COVID-19 patient who presented with abdominal pain (9) . The symptom of abdominal pain in COVID-19 should be carefully treated for infection prevention and control. Narrative information from patients is important to our effort to Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Diseases NIoI. Manual for the Detection of Pathogen 2019-nCoV Ver.2 Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients COVID-19): Relationship to Duration of Infection Medical word use in clinical encounters Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China A c c e p t e d M a n u s c r i p t 11